Oxford PharmaGenesis opens office in Cambridge

Following on from their existing seven offices around the globe, Oxford PharmaGenesis (OPG) have further expanded their coverage, by introducing a brand new office in Cambridge’s new city quarter, CB1. The office has been purposely built in the up-coming area so that it’s in close proximity to major companies as well as the ever-growing Cambridge Biomedical Campus.

Chief Executive Officer, Dr Chris Winchester, stated: “These are exciting times at PharmaGenesis. Opening in Cambridge means we now have a presence in all the MedCity UK hubs. We are close to major pharmaceutical companies, exciting small biotechs and digital health innovators, and we can attract new talent from some of the best academic institutions in the world. Our success comes from our talented people providing high quality communications that ultimately help make a difference to the lives of patients. Cambridge will play an important role in our continued growth.”